pepcan
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2015 (NCT02481414)
Timeline
Indications
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pepcan
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03821272 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2019 | University of Arkansas |
| NCT02481414 | Phase 2 | Oct 1, 2015 | Hoosier Cancer Research Network |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hoosier Cancer Research Network | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Arkansas | Academic/Hospital | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1